Should antihypertensive treatment recommendation differ for patients with and without coronary heart disease? report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Lipid Lowering ◽

Treatment Recommendation ◽

Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])

The American Journal of Cardiology ◽

10.1016/j.amjcard.2015.10.012 ◽

2016 ◽

Vol 117 (1) ◽

pp. 105-115 ◽

Cited By ~ 6

Author(s):

Michael H. Alderman ◽

Barry R. Davis ◽

Linda B. Piller ◽

Charles E. Ford ◽

M. Sarah Baraniuk ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Heart Attack ◽

Treatment Recommendations ◽

Lipid Lowering ◽

Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure and mortality: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Journal of the American Society of Hypertension ◽

10.1016/j.jash.2014.03.025 ◽

2014 ◽

Vol 8 (4) ◽

pp. e13-e14

Author(s):

Paul Muntner ◽

Jeff Whittle ◽

Amy I. Lynch ◽

Lara M. Simpson ◽

Paula Einhorn ◽

...

Keyword(s):

Heart Failure ◽

Blood Pressure ◽

Coronary Heart Disease ◽

Heart Disease ◽

Heart Attack ◽

Lipid Lowering ◽

Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: The Antihypertensive and Lipid Lowering to Prevent Heart Attack Trial (ALLHAT-LLT)

American Heart Journal ◽

10.1016/j.ahj.2009.10.001 ◽

2009 ◽

Vol 158 (6) ◽

pp. 948-955 ◽

Cited By ~ 10

Author(s):

Karen L. Margolis ◽

Kay Dunn ◽

Lara M. Simpson ◽

Charles E. Ford ◽

Jeff D. Williamson ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Usual Care ◽

Heart Attack ◽

Lipid Lowering ◽

Prevent Heart Attack Trial ◽

Black Patients

Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70297-x ◽

2006 ◽

Vol 2006 ◽

pp. 83-85

Author(s):

J.L. Leahy

Keyword(s):

Type 2 Diabetes ◽

Clinical Outcomes ◽

Glucose Concentration ◽

Heart Attack ◽

Fasting Glucose ◽

Lipid Lowering ◽

Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

ACC Current Journal Review ◽

10.1016/j.accreview.2005.08.200 ◽

2005 ◽

Vol 14 (9) ◽

pp. 24

Author(s):

P.K. Whelton ◽

J. Barzilay ◽

W.C. Cushman

Keyword(s):

Type 2 Diabetes ◽

Clinical Outcomes ◽

Glucose Concentration ◽

Heart Attack ◽

Fasting Glucose ◽

Lipid Lowering ◽

Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70595-9 ◽

2006 ◽

Vol 2006 ◽

pp. 464-466

Author(s):

J.L. Leahy

Keyword(s):

Type 2 Diabetes ◽

Clinical Outcomes ◽

Glucose Concentration ◽

Heart Attack ◽

Fasting Glucose ◽

Lipid Lowering ◽

Relationship of Antihypertensive Treatment Regimens and Change in Blood Pressure to Risk for Heart Failure in Hypertensive Patients Randomly Assigned to Doxazosin or Chlorthalidone: Further Analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial

Annals of Internal Medicine ◽

10.7326/0003-4819-137-5_part_1-200209030-00006 ◽

2002 ◽

Vol 137 (5_Part_1) ◽

pp. 313 ◽

Cited By ~ 68

Author(s):

Barry R. Davis

Keyword(s):

Heart Failure ◽

Blood Pressure ◽

Heart Attack ◽

Lipid Lowering ◽

Prevent Heart Attack Trial ◽

Hypertensive Patients ◽

Treatment Regimens ◽

Relationship Of

Fasting Glucose Levels and Incident Diabetes Mellitus in Older Nondiabetic Adults Randomized to Receive 3 Different Classes of Antihypertensive Treatment: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Yearbook of Cardiology ◽

10.1016/s0145-4145(08)70042-x ◽

2007 ◽

Vol 2007 ◽

pp. 77-79 ◽

Cited By ~ 1

Author(s):

W.J. Elliott

Keyword(s):

Diabetes Mellitus ◽

Heart Attack ◽

Fasting Glucose ◽

Incident Diabetes ◽

Lipid Lowering ◽

Prevent Heart Attack Trial ◽

Glucose Levels ◽

To Receive

Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Yearbook of Cardiology ◽

10.1016/s0145-4145(07)70035-7 ◽

2006 ◽

Vol 2006 ◽

pp. 62-64

Author(s):

W.J. Elliott

Keyword(s):

Type 2 Diabetes ◽

Clinical Outcomes ◽

Glucose Concentration ◽

Heart Attack ◽

Fasting Glucose ◽

Lipid Lowering ◽

M.556 LDL-cholesterol levels in patients with coronary heart disease receiving lipid-lowering therapy: Relation to pretreatment LDL-cholesterol and CHD risk status (reality study, Germany)

Atherosclerosis ◽

10.1016/s0021-9150(04)90554-0 ◽

2004 ◽

Vol 5 (1) ◽

pp. 129 ◽

Cited By ~ 1

Author(s):

K KROBOT

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Ldl Cholesterol ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Risk Status ◽

Cholesterol Levels ◽

Lowering Therapy ◽

Chd Risk